贵州中医药大学,贵州省贵阳市南明区市东路50号,550001
987570074@qq.com,(0851)88233089
收稿:2022-07-21,
修回:2022-10-27,
纸质出版:2023-03-17
移动端阅览
代康莉,李燕,张震等.逍遥散加减方对高催乳激素血症肝郁脾虚证模型大鼠下丘脑多巴胺能神经元细胞凋亡及内质网应激的影响[J].中医杂志,2023,64(06):625-632.
DAI Kangli,LI Yan,ZHANG Zhen,et al.Effects of Modified Xiaoyao Powder (逍遥散加减方) on Hypothalamic Dopaminergic Neurons Apoptosis and Endoplasmic Reticulum Stress in Hyperprolactinemia Model Rats with Liver Constraint and Spleen Deficiency Syndrome[J].Journal of Traditional Chinese Medicine,2023,64(06):625-632.
代康莉,李燕,张震等.逍遥散加减方对高催乳激素血症肝郁脾虚证模型大鼠下丘脑多巴胺能神经元细胞凋亡及内质网应激的影响[J].中医杂志,2023,64(06):625-632. DOI: 10.13288/j.11-2166/r.2023.06.014.
DAI Kangli,LI Yan,ZHANG Zhen,et al.Effects of Modified Xiaoyao Powder (逍遥散加减方) on Hypothalamic Dopaminergic Neurons Apoptosis and Endoplasmic Reticulum Stress in Hyperprolactinemia Model Rats with Liver Constraint and Spleen Deficiency Syndrome[J].Journal of Traditional Chinese Medicine,2023,64(06):625-632. DOI: 10.13288/j.11-2166/r.2023.06.014.
目的
2
探讨逍遥散加减方治疗高催乳激素血症(HPRL)肝郁脾虚证的可能作用机制。
方法
2
126只SD大鼠随机分成空白组,模型组,甲磺酸溴隐亭组,逍遥散加减方高、中、低剂量组,每组21只。除空白组外,其他各组均采用甲氧氯普胺腹腔注射联合慢性复合应激法制作HPRL肝郁脾虚证病证结合大鼠模型,总造模周期21天。实验第22天开始空白组与模型组给予4 ml生理盐水灌胃,甲磺酸溴隐亭组给予甲磺酸溴隐亭片0.001 g/(kg·d)灌胃,逍遥散加减方高、中、低剂量组分别给予逍遥散加减方60、30、15 g/(kg·d)灌胃,各组大鼠均灌胃共14天。给药结束次日称量大鼠体质量后,采用免疫荧光法测定下丘脑酪氨酸羟化酶(TH)阳性细胞数;采用ELISA法检测血清催乳素(PRL)含量;采用蛋白免疫印记法检测下丘脑的活化型半胱氨酸蛋白酶3(Cleaved-Caspase3)、C/EBP同源蛋白(CHOP)蛋白含量;原代培养多巴胺能神经元1周后,采用流式细胞仪检测多巴胺能神经元细胞凋亡。
结果
2
与空白组比较,模型组大鼠体质量、TH阳性细胞数降低,PRL含量及大鼠下丘脑组织CHOP、Cleaved-Caspase3蛋白表达量显著升高,多巴胺能神经元细胞凋亡率亦升高(
P
<0.01)。与模型组比较,甲磺酸溴隐亭组和逍遥散加减方高、中、低剂量组血清PRL含量显著降低,TH阳性细胞数升高;甲磺酸溴隐亭组及逍遥散加减方高剂量组CHOP蛋白表达降低,甲磺酸溴隐亭组和逍遥散加减方各剂量组Cleaved-Caspase3蛋白表达亦降低;甲磺酸溴隐亭组多巴胺能神经元细胞凋亡率显著升高,而逍遥散加减方各剂量组细胞凋亡率降低(
P
<0.05或
P
<0.01)。与逍遥散加减方中剂量组比较,逍遥散加减方高、低剂量组血清PRL含量显著升高(
P
<0.05或
P
<0.01)。与甲磺酸溴隐亭组和逍遥散加减方高剂量组比较,逍遥散加减方中、低剂量组CHOP蛋白表达升高,逍遥散加减方低剂量组Cleaved-Caspase3蛋白降低(
P
<0.01)。
结论
2
逍遥散加减方可能通过抑制CHOP介导的内质网应激相关凋亡通路减轻HPRL大鼠模型的多巴胺能神经元损伤。
Objective
2
To study the possible mechanism of
Modified Xiaoyao Powder
(逍遥散加减方, MXP) in the treatment of hyperprolactinemia (HPRL) with liver constraint and spleen deficiency syndrome.
Methods
2
A total of 126 SD rats were randomly divided into blank group, model group, bromocriptine mesylate group, high-, medium- and low-dose MXP groups, with 21 rats in each group. Except for the blank group, all other groups used intraperitoneal injection of metoclopramide plus chronic compound stress method to develop the HPRL model with liver constraint and spleen deficiency syndrome, taking a total modeling period of 21 days. Since the 22nd day of the experiment, the blank group and the model group were given intragastric administration of 4 ml of normal saline, and the bromocriptine mesylate group was given 0.001 g/(kg·d) of bromocriptine mesylate tablets by gavage; MXP at the dosage of 60, 30, and 15 g/(kg·d) was administered by gavage in the high-, medium- and low-dose group, respectively. The administration period was 14 days for all groups. After weighing the rats on the next day of last administration, the number of hypothalamic tyrosine hydroxylase (TH) positive cells was determined by immunofluorescence; the serum prolactin (PRL) content was detected by ELISA; the protein content of activated cysteine protease 3 (Cleaved-Caspase3) and C/EBP homologous protein (CHOP) in the hypothalamus was detected by Western blotting. The apoptosis of dopaminergic neurons was detected by flow cytometry after primary culture for 1 week.
Results
2
Compared to those in the blank group, the body weight and the number of TH positive cells in the model group decreased, while the content of PRL, the expression of CHOP and Cleaved-Caspase3 proteins in the hypothalamus tissue increased significantly, as well as the apoptosis rate of dopaminergic neurons (
P
<0.01). Compared to those in the model group, the serum PRL content significantly decreased while the number of TH positive cells increased in the bromocriptine mesylate group and high-, medium-, and low-dose MXP groups; the expression of CHOP protein decreased in the bromocriptine mesylate group and the high-dose MXP group; the expression of Cleaved-Caspase3 protein in the bromocriptine mesylate group and MXP all dose groups also decreased; the apoptosis rate of dopaminergic neurons in the bromocriptine mesylate group increased significantly, while that of MXP all dose groups decreased (
P
<0.05 or
P
<0.01). Compared to those in the medium-dose MXP group, the serum PRL level in the high- and low-dose groups significantly increased (
P
<0.05 or
P
<0.01). Compared to those in the bromocriptine mesylate group and the high-dose MXP group, the expression of CHOP protein in the medium- and low-dose groups increased, and the Cleaved-Caspase3 protein in the low-dose group decreased (
P
<0.01).
Conclusion
2
MXP may alleviate dopaminergic neuron damage in HPRL rat model by inhibiting CHOP-mediated endoplasmic reticulum stress-related apoptosis pathway.
ILHAN M , TURGUT S . Evaluation of the patients with hyperprolactinemia [J]. Med J Islam World Academ Sci , 2017 , 25 ( 2 ): 25 - 30 .
SAMPERI I , LITHGOW K , KARAVITAKI N . Hyperprolactinaemia [J]. J Clin Med , 2019 , 8 ( 12 ): 2203 .
MOHANKUMAR SM , KASTURI BS , SHIN AC , et al . Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia [J]. Am J Physiol Regul Integr Comp Physiol , 2011 , 300 ( 3 ): R693 - R699 .
ALMANZA A , CARLESSO A , CHINTHA C , et al . Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications [J]. FEBS J , 2019 , 286 ( 2 ): 241 - 278 .
丁良才 , 白波 . 神经退行性疾病与内质网应激 [J]. 中华行为医学与脑科学杂志 , 2017 , 26 ( 2 ): 183 - 187 .
YI S , CHEN K , ZHANG L , et al . Endoplasmic reticulum stress is involved in stress-induced hypothalamic neuronal injury in rats via the PERK-ATF4-CHOP and IRE1-ASK1-JNK pathways [J]. Front Cell Neurosci , 2019 , 13 : 190 . doi: 10.3389/fncel.2019.00190 http://dx.doi.org/10.3389/fncel.2019.00190 .
刘福珍 , 刘清青 . 逍遥散加减汤治疗高泌乳素血症临床研究 [J]. 新中医 , 2016 , 48 ( 6 ): 153 - 155 .
刘凯鑫 , 李燕 , 黄世梅 , 等 . 逍遥散加减方对高催乳素血症大鼠多巴胺转运体的影响 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 4 ): 51 - 57 .
许露 , 李燕 , 张芳 , 等 . 逍遥散加减对高泌乳素血症模型大鼠中枢多巴胺受体ERK信号转导通路的影响 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 15 ): 70 - 76 .
王培培 , 姚树永 , 杜向东 . 高催乳素血症动物模型的研究进展 [J]. 医学综述 , 2018 , 24 ( 11 ): 2110 - 2113 .
ANTONIUK S , BIJATA M , PONIMASKIN E , et al . Chronic unpredictable mild stress for modeling depression in rodents: Meta-analysis of model reliability [J]. Neurosci Biobehav Rev , 2019 , 99 : 101 - 116 . doi: 10. 1016/j.neubiorev http://dx.doi.org/10.1016/j.neubiorev .
赵博 , 柴丽 , 吴大梅 , 等 . 复合多因素方法复制肝郁脾虚证动物模型的实验研究 [J]. 成都中医药大学学报 , 2013 , 36 ( 3 ): 10 - 14 .
刘佳 , 许可 , 张兰 . 肝郁脾虚证动物模型评价方法 [J]. 中医药导报 , 2019 , 25 ( 23 ): 120 - 122 .
黄继汉 , 黄晓晖 , 陈志扬 , 等 . 药理试验中动物间和动物与人体间的等效剂量换算 [J]. 中国临床药理学与治疗学 , 2004 , 9 ( 9 ): 1069 - 1072 .
唐东昕 , 杨柱 , 金露露 , 等 . 刘尚义治疗月经不调用药规律数据挖掘 [J]. 中医杂志 , 2016 , 57 ( 12 ): 1019 - 1022 .
周姗姗 , 高彩霞 , 张新霞 . 高泌乳素血症的中西医治疗进展 [J]. 世界最新医学信息文摘 , 2017 , 17 ( 68 ): 52 - 53 .
HU H , TIAN M , DING C , et al . The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection [J]. Front Immunol , 2019 , 9 : 3083 . doi: 10. 3389/fimmu.2018.03083 http://dx.doi.org/10.3389/fimmu.2018.03083 .
IURLARO R , MUNOZ-PINEDO C . Cell death induced by endoplasmic reticulum stress [J]. FEBS J , 2016 , 283 ( 14 ): 2640 - 2652 .
OAKES SA , PAPA FR . The role of endoplasmic reticulum stress in human pathology [J]. Annu Rev Pathol , 2015 , 10 : 173 - 194 . doi: 10.1146/annurev-pathol-012513-104649 http://dx.doi.org/10.1146/annurev-pathol-012513-104649 .
董彪 . 内质网源性转录因子CHOP在肾脏缺血再灌注损伤中的作用和机制研究 [D]. 吉林 : 吉林大学 , 2014 .
张振英 , 刘秀华 , 孙胜 , 等 . C/EBP同源蛋白介导的内质网应激相关凋亡途径参与腹主动脉狭窄致大鼠心肌肥厚 [J]. 生理学报 , 2009 , 61 ( 2 ): 161 - 168 .
张思泉 , 张莹雯 , 帅瑜 , 等 . 当归补血汤对糖尿病肾病大鼠肾组织ATF6、CHOP、Caspase-3表达的影响 [J]. 上海中医药杂志 , 2018 , 52 ( 4 ): 91 - 95 .
HUANG H , AN Y , JIAO W , et al . CHOP/caspase-3 signal pathway involves in mitigative effect of selenium on lead-induced apoptosis via endoplasmic reticulum pathway in chicken testes [J]. Environ Sci Pollut Res Int , 2018 , 25 ( 19 ): 18838 - 18845 .
WHITE RB , THOMAS MG . Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson's disease [J]. CNS Neurol Disord Drug Targets , 2012 , 11 ( 4 ): 340 - 349 .
0
浏览量
11
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号